Abstract
Background
Despite the growing emphasis on the inclusion of ethnic minority patients in research, there is little published on the recruitment of these populations especially to randomised, community based, lifestyle intervention trials in the UK.
Methods
We share our experience of recruitment to screening in the PODOSA (Prevention of Diabetes and Obesity in South Asians) trial, which screened 1319 recruits (target 1800) for trial eligibility. A multi-pronged recruitment approach was used. Enrolment via the National Health Service included direct referrals from health care professionals and written invitations via general practices. Recruitment within the community was carried out by both the research team and through our partnerships with local South Asian groups and organisations. Participants were encouraged to refer friends and family throughout the recruitment period.
Results
Health care professionals referred only 55 potential participants. The response to written invitations via general practitioners was 5.2%, lower than reported in other general populations. Community orientated, personal approaches for recruitment were comparatively effective yielding 1728 referrals (82%) to the screening stage.
Conclusions
The PODOSA experience shows that a community orientated, personal approach for recruiting South Asian ethnic minority populations can be successful in a trial setting. We recommend that consideration is given to cover recruitment costs associated with community engagement and other personalised approaches. Researchers should consider prioritising approaches that minimise interference with professionals' work and, particularly in the current economic climate, keep costs to a minimum. The lessons learned in PODOSA should contribute to future community based trials in South Asians.
Trial Registration
Current Controlled Trials ISRCTN25729565
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The University of Edinburgh, Medical School, Teviot Place, Centre for Population Health Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000000419367988)
2 University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, UK (GRID:grid.8756.c) (ISNI:000000012193314X)
3 Western General Hospital, Metabolic Unit, Anne Ferguson Building, Edinburgh, UK (GRID:grid.417068.c) (ISNI:0000000406249907)
4 South Ostrobothnia Central Hospital, Seinäjoki, Finland (GRID:grid.415465.7) (ISNI:0000 0004 0391 502X); Hospital Universitario La Paz, Red RECAVA Grupo RD06/0014/0015, Madrid, Spain (GRID:grid.81821.32) (ISNI:0000000089709163); Danube-University Krems, Centre for Vascular Prevention, Krems, Austria (GRID:grid.15462.34) (ISNI:0000000121085830)